Dibutyltin di(acetate)
Dibutyltin di(acetate) figure à l’annexe II en tant que substance interdite dans les produits cosmétiques mis sur le marché de l’UE.
Détails de la fiche
Nom chimique
Dibutyltin di(acetate)
Informations réglementaires
Données clés
Identité et propriétés chimiques

Dibutyltin diacetate
Dibutyltin diacetate is a clear yellow liquid. (NTP, 1992) — CAMEO Chemicals
- Nom IUPAC
- [acetyloxy(dibutyl)stannyl] acetate
- Formule moléculaire
- C12H24O4Sn
- Masse moléculaire
- 351.03 g/mol
- Masse exacte
- 352.069662 Da
- Surface polaire topologique
- 52,6 Ų
- Donneurs de liaisons hydrogène
- 0
- Accepteurs de liaisons hydrogène
- 4
- Unités covalentes
- 1
- Stéréocentres définis
- 0
Également connu sous le nom de
16 autres noms signalés
Identifiants de bases de données externes
- EPA DTXSID:DTXSID3020419
Preuves issues de bases de données scientifiques complémentaires
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Boiling Point: 266 °F at 2 mmHg (NTP, 1992) Source: CAMEO Chemicals
- Boiling Point: 130 °C @ 2 mm Hg Source: Hazardous Substances Data Bank (HSDB)
- Boiling Point: 130 °C @760 [mm Hg] Source: PAC Chemical Database, U.S. Department of Energy
- Color/Form: COLORLESS LIQUID Source: Hazardous Substances Data Bank (HSDB)
- Color/Form: Clear, yellow liquid Source: Hazardous Substances Data Bank (HSDB)
- Density: 1.31 at 77 °F (NTP, 1992) - Denser than water; will sink Source: CAMEO Chemicals
- Density: 1.31 at 25 °C Source: Hazardous Substances Data Bank (HSDB)
- Density: 1.31 @25 °C Source: PAC Chemical Database, U.S. Department of Energy
- Flash Point: 290 °F (NTP, 1992) Source: CAMEO Chemicals
- Flash Point: 143 °C (290 °F) (OPEN CUP) Source: Hazardous Substances Data Bank (HSDB)
- LogP: log Kow=1.27 Source: Hazardous Substances Data Bank (HSDB)
- Melting Point: less than 53.6 °F (NTP, 1992) Source: CAMEO Chemicals
- Melting Point: 10 °C Source: Hazardous Substances Data Bank (HSDB)
- Odor: Slight acetic acid Source: Hazardous Substances Data Bank (HSDB)
- Physical Description: Dibutyltin diacetate is a clear yellow liquid. (NTP, 1992) Source: CAMEO Chemicals
- Physical Description: CBI; Liquid Source: EPA Chemical Data Reporting (CDR)
- Physical Description: Clear yellow liquid; [Hawley] Colorless or yellow liquid; mp = 10 deg C; [HSDB] Colorless liquid; [MSDSonline] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Refractive Index: INDEX OF REFRACTION: 1.482 @ 20 °C Source: Hazardous Substances Data Bank (HSDB)
- Solubility: less than 1 mg/mL at 59 °F; forms white precipitate (NTP, 1992) Source: CAMEO Chemicals
- Solubility: Sol in water and most org solvents Source: Hazardous Substances Data Bank (HSDB)
- Vapor Pressure: 1.3 [mmHg] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Vapor Pressure: 1.3 mm Hg at 20 °C Source: Hazardous Substances Data Bank (HSDB)
- Vapor Pressure: 1.3 [mm Hg] @20 °C Source: PAC Chemical Database, U.S. Department of Energy
- Viscosity: 18 cP at 25 °C Source: Hazardous Substances Data Bank (HSDB)
- Substance: Dibutyltin diacetate Source: NTP Technical Reports
- NTP Technical Report: TR-183: Bioassay of Dibutyltin Diacetate for Possible Carcinogenicity (CASRN 1067-33-0) (1979 ) Source: NTP Technical Reports
- Peer Review Date: 10/25/78 Source: NTP Technical Reports
- Conclusion for Male Rat: No Evidence Source: NTP Technical Reports
- Conclusion for Female Rat: Inadequate Experiment Source: NTP Technical Reports
- Conclusion for Male Mice: No Evidence Source: NTP Technical Reports
- Conclusion for Female Mice: No Evidence Source: NTP Technical Reports
- Summary: Under the conditions of this bioassay, there was no conclusive evidence for the carcinogenicity of dibutyltin diacetate in male Fischer 344 rats or B6C3F1 mice of either sex. The loss of tissues taken from high dose female rats in this bioassay precluded an evaluation of the carcinogenicity of dibutyltin diacetate to female Fischer 344 rats. Source: NTP Technical Reports
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). Source: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Oral (L308) ; inhalation (L308) ; dermal (L308) Source: Toxin and Toxin Target Database (T3DB)
- First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. IMMEDIATELY call a hospital or poison control center even if no symptoms (such as redness or irritation) develop. IMMEDIATELY transport the victim to a hospital for treatment after washing the affected areas.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. IMMEDIATELY call a physician and be prepared to transport the victim to a hospital even if no symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop. Provide proper respiratory protection to rescuers entering an unknow Source: CAMEO Chemicals
- Signal: Danger Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- GHS Hazard Statements: H341: Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H360FD: May damage fertility; May damage the unborn child [Danger Reproductive toxicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- Precautionary Statement Codes: P203, P260, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement) Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- Note: This chemical does not meet GHS hazard criteria for 1.5% (10 of 665) of reports. Source: European Chemicals Agency (ECHA)
- Signal: Danger Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H314 (94.7%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H317 (82%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H318 (76.5%): Causes serious eye damage [Danger Serious eye damage/eye irritation]; H341 (82.4%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]; H360 (64.4%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H360FD (18.2%): May damage fertility; May damage the unborn child [Danger Reproductive toxicity]; H370 (82%): Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H372 (92.3%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H400 (58.6%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]; H410 (89%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P260, P261, P264, P264+P265, P270, P272, P273, P280, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P308+P316, P316, P317, P318, P319, P321, P333+P317, P362+P364, P363, P391, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 665 reports by companies from 44 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 10 of 665 reports by companies.; There are 43 notifications provided by 655 of 665 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
- Signal: Danger Source: NITE-CMC
- GHS Hazard Statements: H300: Fatal if swallowed [Danger Acute toxicity, oral]; H360: May damage fertility or the unborn child [Danger Reproductive toxicity]; H373: May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]; H400: Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]; H410: Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard] Source: NITE-CMC
- Precautionary Statement Codes: P203, P260, P264, P270, P273, P280, P301+P316, P318, P319, P321, P330, P391, P405, and P501 (click each P-code to see the statement) Source: NITE-CMC
- Signal: Danger Source: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Health Effects: Breathing or swallowing, or skin contact with organotins, can interfere with the way the brain and nervous system work, causing death in severe cases. Organic tin compounds may also damage the immune and reproductive system. (L307, L308) Source: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: Organotin compounds produce neurotoxic and immunotoxic effects. Organotins may directly activate glial cells contributing to neuronal cell degeneration by local release of pro-inflammatory cytokines, tumor necrosis factor-_, and/or interleukins. They may also induce apoptosis by direct action on neuronal cells. Organotin compounds stimulate the neuronal release of and/or decrease of neuronal cell uptake of neurotransmitters in brain tissue, including aspartate, GABA, glutamate, norepinephrine, and serotonin. This may be either a contributing factor to or result of the neuronal cell loss. The immunotoxic effects of organotins are characterized by thymic atrophy caused by the suppression of proliferation of immature thymocytes and apoptosis of mature thymocytes. Organotin compounds are believed to exert these effects by suppressing DNA and protein synthesis, inducing the expression of genes involved in apoptosis (such as nur77), and disrupting the regulation of intracellular calcium levels, giving rise to the uncontrolled production of reactive oxygen species, release of cytochrome c to the cytosol, and the proteolytic and nucleolytic cascade of apoptosis. The suppression of prolifer Source: Toxin and Toxin Target Database (T3DB)
- Consumer Uses: Stabilizing agent Source: EPA Chemical Data Reporting (CDR)
- Industry Uses: Catalyst; Processing aids not otherwise specified Source: EPA Chemical Data Reporting (CDR)
- Sources/Uses: Used as stabilizer for polyvinyl chloride, a catalyst for manufacturing silicone and urethane foams, and a curing agent for silicone elastomers; [HSDB] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Industrial Processes with risk of exposure: Plastic Composites Manufacturing [Category: Industry] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Uses: Stabilizer for chlorinated org cmpd; catalyst for condensation reactions. Source: Hazardous Substances Data Bank (HSDB)
- Uses: CATALYST FOR MFR OF SILICONE AND URETHANE FOAMS, FOR ESTERIFICATION REACTIONS Source: Hazardous Substances Data Bank (HSDB)
- Uses: The largest single industrial application for organotin compounds is in the stabilization of polyvinyl chloride. /Diorganotin compounds/ Source: Hazardous Substances Data Bank (HSDB)
- Uses: Dialkyltin compounds are the best general-purpose stabilizers for polyvinyl chloride, esp if colorlessness & transparency are required. ... Diorganotin compounds have been used increasingly as catalysts for high resiliency foam in automotive seating. /Diorganotin compounds/ Source: Hazardous Substances Data Bank (HSDB)
- Uses: For more Uses (Complete) data for DIBUTYLTIN DIACETATE (7 total), please visit the HSDB record page. Source: Hazardous Substances Data Bank (HSDB)
Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source
Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.
Couverture des sources complémentaires et état des correspondances
| Source | Résultat | Vérifié |
|---|---|---|
| EMBL-EBI ChEBI | Aucune fiche exacte | 2026-08-31 |
| NIH PubChem PUG-View | Correspondance exacte | 2026-08-31 |
Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.
Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.
Fiches associées pour Dibutyltin di(acetate)
Les correspondances directes sont limitées pour cette fiche ; des entrées voisines de l’annexe II sont donc également affichées.
Dibutyltin bis(2-ethylhexanoate)
Barium diboron tetraoxide
Desmedipham (ISO); ethyl 3-phenylcarbamoyloxyphenylcarbamate
2,2-dimethylpropan-1-ol,tribromo derivative; 3-bromo-2,2-bis(bromomethyl)propan-1-ol
Triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyc…
2,4,6-tri-tert-butylphenol
Thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroami…
4,4’-sulphonyldiphenol; bisphenol S
Imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid
Ce que signifie l’annexe II pour Dibutyltin di(acetate)
Dibutyltin di(acetate) figure comme substance interdite à l’annexe II du règlement (CE) n° 1223/2009 relatif aux produits cosmétiques et ne doit pas être ajouté intentionnellement. L’article 17 traite séparément des traces involontaires, techniquement inévitables dans le respect des bonnes pratiques de fabrication et compatibles avec l’exigence de sécurité de l’article 3.
Les formulateurs doivent contrôler leurs ingrédients et matières premières afin de s’assurer qu’aucun ne contient cette substance. Les fournisseurs doivent fournir, sur demande, une documentation confirmant son absence.
La page fait également apparaître 12 fiches d’annexe associées présentant des identifiants, une logique d’annexe ou des schémas de dénomination qui se recoupent.
Liste de contrôle de conformité
- Vérifiez que cette substance est absente de toutes les matières premières et formulations finies.
- Demandez aux fournisseurs de matières premières une attestation d’absence ou un certificat d’analyse.
- Consignez le résultat du contrôle dans le dossier d’information produit (DIP).
Questions fréquentes
Note de source pour la fiche Dibutyltin di(acetate) de l’annexe II
Cette page résume une fiche de l’annexe II pour Dibutyltin di(acetate) à partir de documents publics de la Commission européenne sur les cosmétiques et ajoute les correspondances d’inventaire ou d’identifiants associées lorsqu’elles sont disponibles.
Utilisez cette page de fiche pour examiner les conditions de l’annexe II pour Dibutyltin di(acetate), mais confirmez toute décision réglementaire finale auprès du libellé officiel en vigueur de l’annexe et des fichiers sources.
Outils et étapes suivantes
Vérifiez votre formule
Collez une liste INCI complète pour détecter Dibutyltin di(acetate) et d’autres fiches d’annexe de l’UE signalées en une seule passe.
Vérificateur INCIComparer des entrées
Comparez Dibutyltin di(acetate) côte à côte avec une autre fiche d’annexe pour examiner les différences de restrictions, de concentrations et d’annexe.
ComparerParcourir l’annexe
Consultez toutes les fiches de l’annexe II et comparez les conditions réglementaires entre les substances de cette annexe.
Ouvrir l’annexe II